Table 3.
LLINs | Mosquito tested per site | Bio-efficacy indexes | Study districts | ||
---|---|---|---|---|---|
Balama (A. funestus) | Mocuba (A. funestus) | Milange (A. gambiae) | |||
Olyset | 360 | KD 60 (±se) | 35.55 (±3.15) | 49.14 (±2.47) | 57.5 (±2.71) |
Mortality rate (±se) | 20.9 (±2.34) | 38.07 (±3.07) | 40.77 (±2.82) | ||
Permanet 2.0 | 360 | KD 60 (±se) | 69.72 (±3.40) | 78.61 (±2.18) | 91.25 (±1.30) |
Mortality rate (±se) | 60.48 (±3.64) | 81.94 (±2.32) | 89.65 (±1.65) | ||
Permanet 3.0 | 600 | KD 60 (±se) | 93.33 (±1.12) | 85.16 (±1.43) | 99.64 (±0.36) |
Mortality rate (±se) | 85.5 (±2.09) | 90.16 (±1.27) | 98.92 (±0.61) | ||
NetProtect | 360 | KD 60 (±se) | 61.38 (±2.79) | 62.22 (±2.52) | 83.88 (±1.61) |
Mortality rate (±se) | 23.95 (±2.34) | 63.61 (±2.95) | 78.87 (±3.56) | ||
Interceptor | 360 | KD 60 (±se) | – | – | 80.83 (±1.87) |
Mortality rate (±se) | – | – | 77.84 (±2.16) |
(–) Not tested
Highlighted cell indicates where significant difference between knockdown and mortality rate was found at 5 % significance level